Medscape Dermatology Headlines

FDA Approves Romidepsin for Refractory Cutaneous T-Cell Lymphoma

Fri, 6 Nov 2009 16:58:08 EST

The FDA has approved the HDAC inhibitor romidepsin for the treatment of cutaneous T-cell lymphoma in patients who have received at least 1 prior systemic therapy.
Medscape Medical News

Lichen Planus and dyslipidaemia: a Case–control Study

Fri, 6 Nov 2009 12:00:00 EST

This case study investigates the association between lichen planus and dyslipidaemia.
The British Journal of Dermatology

In Mycosis Fungoides, Immunophenotypes May Vary Between Skin and Blood

Wed, 4 Nov 2009 08:35:05 EST

T-cell immunophenotype of mycosis fungoides involving the skin varies from that involving the blood in more than half the cases of this cutaneous T-cell lymphoma.
Medscape Medical News

In Nodal Metastatic Melanoma, Radiation May Be New Standard of Care

Tue, 3 Nov 2009 14:45:55 EST

Patients with melanoma had a lower risk for a return of disease in the lymph nodes when treated with adjuvant radiation.
Medscape Medical News

Can Doctors Ever Tell Patients They Are Cured of Cancer?

Mon, 2 Nov 2009 16:30:57 EST

In her first Medscape video blog, Dr. Kathy Miller asks whether doctors should avoid using the term “cured” to describe patients who have been in remission for several years.
Medscape Hematology-Oncology

Vascular Endothelial Cell Function Is Impaired in Neurofibromatosis 1 Patients

Mon, 2 Nov 2009 10:08:41 EST

A study suggests that an increased population of circulating proinflammatory cells might contribute to the development of vascular disease in neurofibromatosis 1 patients.
Medscape Medical News